Delivery Order SPE2DB22D1106-SPE2DB24FEHC5
- Not listed
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of 4,562,987,045 units of Duloxetine Hydrochloride Delayed-Release 40 mg Capsules. The contract has a ceiling value of $3,091.80 and a completion date of December 5, 2023. This is a Firm Fixed Price Delivery Order contract, and it is not designated as a set-aside. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Duloxetine Hydrochloride Delayed-Release 40 mg capsules. The delivery order, valued at $1,039.68, is under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that has a ceiling value of up to $999,999,999 through December 2025. This contract does not have a set-aside designation and is for a Firm Fixed Price...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The $1,684.04 firm fixed price delivery order is for the supply of 4563942418 - Duloxetine HCl DR 40 mg capsules in 30-count packages. The contract has a performance period through March 13, 2024 and does not utilize any set-aside designations. Amerisourcebergen Drug Corp is an...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $2,756.34 firm fixed price delivery order is for the supply of 4564040998 - Duloxetine HCl DR 40 mg capsules in 30-count packages. This award is under an indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with a potential value of $999,999,999.00 and a performance period...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,674.67 firm fixed-price delivery order is for the supply of 4,564,690 units of Duloxetine HCL DR 40 mg capsules. The contract has an ultimate completion date of May 23, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,075.68 firm-fixed-price delivery order is for the supply of 4567655738 - Duloxetine HCL DR 40 MG Capsules, 30s. The contract has an ultimate completion date of March 24, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
- This federal contract award, valued at $2,418.90, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Duloxetine HCL DR 40 MG capsules, with a performance period ending on May 2, 2025. The contract is a Firm Fixed Price Delivery Order, without any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,150.02 firm-fixed-price delivery order is for the supply of 4566572527 - Duloxetine HCL DR 40 MG Capsules (30s). The contract has an ultimate completion date of December 2, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor in the United States. The contract, valued at $1,936.92, is for the delivery of Duloxetine Hydrochloride delayed-release capsules in 30-count bottles. It was awarded on September 24, 2024, with a completion date of September 25, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type, and there was no set-aside used. This award is...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,218.99 firm fixed-price delivery order is for the supply of 4564860751 - Duloxetine HCL DR 40 MG Capsules in quantities of 30s. The contract has an ultimate completion date of June 11, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB24FEHC5Delivery Order
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $9,244.48 firm fixed price delivery order is for the supply of 4,564,097,792 units of Duloxetine Hydrochloride delayed-release 40 mg capsules. The award is part of a larger indefinite delivery contract (IDC) between DLA and Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. This IDC serves as the primary contract vehicle for Amerisourcebergen to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. No set-aside designation was used for this contract.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.2k | 3/27/24 |